10-Nov-2025 7:00 AM CST - Business Wire Maravai LifeSciences Announces November 2025 Investor Conference Schedule Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November. On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference in New York City, NY. On November 19, 2025, at 10:00 a.m. GMT, Raj Asarpota, Chief Fin
6-Nov-2025 3:01 PM CST - Business Wire Maravai LifeSciences Reports Third Quarter 2025 Financial Results Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates. Quarterly Results: Revenue of $41.6 million, Net loss of $(45.1) million, and Adjusted EBITDA of $(10.8) million We exited the third quarter confident about the future of our business. Cygnus co
22-Oct-2025 3:01 PM CST - Business Wire Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (800) 579-2543 or (785) 424-1789 and reference M
10-Nov-2025 7:00 AM CST - Business Wire Maravai LifeSciences Announces November 2025 Investor Conference Schedule Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November. On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference in New York City, NY. On November 19, 2025, at 10:00 a.m. GMT, Raj Asarpota, Chief Fin
6-Nov-2025 3:01 PM CST - Business Wire Maravai LifeSciences Reports Third Quarter 2025 Financial Results Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates. Quarterly Results: Revenue of $41.6 million, Net loss of $(45.1) million, and Adjusted EBITDA of $(10.8) million We exited the third quarter confident about the future of our business. Cygnus co
22-Oct-2025 3:01 PM CST - Business Wire Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (800) 579-2543 or (785) 424-1789 and reference M
